Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

被引：0
作者：
Anna Rydén
Fiona Blackhall
Hye Ryun Kim
Rathi N. Pillai
Lauren Braam
Mona L. Martin
Andrew Walding
机构：
[1] AstraZeneca Gothenburg,Division of Molecular and Clinical Cancer Sciences
[2] University of Manchester,Department of Medical Oncology, Yonsei Cancer Center
[3] The Christie NHS Foundation Trust,Department of Hematology and Medical Oncology, School of Medicine
[4] Yonsei University College of Medicine,undefined
[5] Winship Cancer Institute of Emory University,undefined
[6] Health Research Associates Inc.,undefined
[7] AstraZeneca R&D,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2017年 / 10卷
关键词：
Epidermal Growth Factor Receptor; Initial Interview; Poor Appetite; Bothersome Symptom; Transcript Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：593 / 603
页数：10
相关论文
共 50 条
  • [21] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
    Akamatsu, Hiroaki
    Katakami, Nobuyuki
    Okamoto, Isamu
    Kato, Terufumi
    Kim, Young Hak
    Imamura, Fumio
    Shinkai, Masaharu
    Hodge, Rachel A.
    Uchida, Hirohiko
    Hida, Toyoaki
    CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
  • [22] Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer
    Karaca, Halit
    Geredeli, Caglayan
    Kaplan, M. Ali
    Demirci, Umut
    Alici, Suleyman
    Artac, Mehmet
    Isikdogan, Abdurrahman
    Benekli, Mustafa
    Balakan, Ozan
    Arpaci, Erkan
    Budakoglu, Burcin
    Uncu, Dogan
    Guler, Tunc
    Berk, Veil
    Ozkan, Metin
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (01): : 1 - 6
  • [23] Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
    Hirsch, F. R.
    Varella-Garcia, M.
    Cappuzzo, F.
    McCoy, J.
    Bemis, L.
    Xavier, A. C.
    Dziadziuszko, R.
    Gumerlock, P.
    Chansky, K.
    West, H.
    Gazdar, A. F.
    Crino, L.
    Gandara, D. R.
    Franklin, W. A.
    Bunn, P. A., Jr.
    ANNALS OF ONCOLOGY, 2007, 18 (04) : 752 - 760
  • [24] QT interval prolongation related to afatinib treatment in a patient with metastatic non-small-cell lung cancer
    Demircan, Nazim Can
    Telli, Tugba Akin
    Tuylu, Tugba Basoglu
    Arikan, Rukiye
    Kocakaya, Derya
    Sahin, Ahmet Anil
    Ercelep, Ozlem
    Dane, Faysal
    Yumuk, Perran Fulden
    CURRENT PROBLEMS IN CANCER, 2020, 44 (06)
  • [25] Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?
    Juergens R.
    Brahmer J.
    Current Oncology Reports, 2007, 9 (4) : 255 - 264
  • [26] Osimertinib in the Treatment of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
    Pan, Jie
    Cai, Xiaoping
    Cao, Zhuo
    Pan, Jiongwei
    Zheng, Hao
    PHARMACOLOGY, 2023, 108 (01) : 8 - 16
  • [27] Smoking History as a Predictive Factor of Treatment Response in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    Mitchell, Paul
    Mok, Tony
    Barraclough, Helen
    Strizek, Alena
    Lew, Rebecca
    van Kooten, Maximiliano
    CLINICAL LUNG CANCER, 2012, 13 (04) : 239 - 251
  • [28] First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer
    Yin Y.-M.
    Geng Y.-T.
    Shao Y.-F.
    Hu X.-L.
    Li W.
    Shu Y.-Q.
    Wang Z.-X.
    Journal of Experimental & Clinical Cancer Research, 29 (1)
  • [29] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [30] Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience
    Ulivi, Paola
    Petracci, Elisabetta
    Canale, Matteo
    Priano, Ilaria
    Capelli, Laura
    Calistri, Daniele
    Chiadini, Elisa
    Cravero, Paola
    Rossi, Alice
    Delmonte, Angelo
    Crino, Lucio
    Bronte, Giuseppe
    BIOMEDICINES, 2021, 9 (10)
12345